Premium
Re: Using the 21‐gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917–923.
Author(s) -
Bear Harry D.,
Wan Wen,
Robidoux André,
Rubin Peter,
Limentani Steven,
White Jr Richard L.,
Granfortuna James,
Hopkins Judith O.,
Oldham Dwight,
Rodriguez Angel,
Sing Amy P.
Publication year - 2018
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24798
Subject(s) - medicine , breast cancer , oncology , neoadjuvant therapy , core biopsy , multicenter trial , multicenter study , cancer , randomized controlled trial
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom